Pharmacology and drug development

I endeavour to integrate and optimise the pre-clinical development and science-led clinical application of novel therapies and novel therapeutic combinations, including first into human (phase I) and associated studies. My research goal is to identify successful, new therapeutic approaches for the treatment of patients with cancer with much of my effort focussing on pancreatic cancer.

For more information see my Department of Oncology webpage: